| Title: |
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors |
| Authors: |
Eads, Jennifer R.Aff1; Krishnamurthi, Smitha S.Aff1; Saltzman, JoelAff1; Bokar, Joseph A.Aff1; Savvides, PanosAff2; Meropol, Neal J.Aff3, Aff4; Gibbons, JosephAff1; Koon, HenryAff1; Sharma, NeeleshAff5; Rogers, LisaAff1; Pink, John J.Aff3; Xu, YanAff6; Beumer, Jan H.Aff7; Riendeau, JohnAff1; Fu, PingfuAff3; Gerson, Stanton L.Aff1; Dowlati, AfshinAff1, IDs1063702000962x_cor17 |
| Source: |
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 39(1):142-151 |
| Database: |
Springer Nature Journals |